30-Day Mortality Down During Joint Commission Survey Weeks
Patients admitted during survey weeks (versus non-survey weeks) have significantly lower mortality
ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
FDA: Gout Drug Uloric Increases Risk of Death
Medication is associated with increased risk of heart-related death and death from all causes
Review: Paroxetine Reduces Vasomotor Symptoms
Moderate quality evidence shows reduction in frequency of hot flashes with paroxetine
Short Time to Eligibility for ART in Young HIV-Infected Adults
Median time for antiretroviral therapy eligibility was shorter for males than females
ASN: eGFR No Different With Sparsentan, Irbesartan in Focal Segmental Glomerulosclerosis
No difference in eGFR slope with sparsentan versus irbesartan among patients with focal segmental glomerulosclerosis
Low Incidence of Diabetic Ketoacidosis With Canagliflozin
Canagliflozin-treated patients with type 2 diabetes have low incidence of serious adverse DKA events
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases
Influenza vaccination rates higher for those receiving one of six intervention letters versus usual care
Pfizer Sends First Data to FDA on COVID-19 Vaccines for Younger Children
Agency has said it could authorize a vaccine for younger children in a matter of weeks after receipt of trial data
FDA Safety Announcement Affected Bisphosphonate Use
Four percent decrease in odds of bisphosphonate use each quarter after safety announcement for a-fib risk
